Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives $25.71 Consensus PT from Brokerages
Shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) have received an average recommendation of “Buy” from the nine analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to […]
Shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) have received an average recommendation of “Buy” from the nine analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to […]
